Tru-D News, Tru-D Technology, Uncategorized

Tru-D and C. diff

Clostridium difficile or C. diff as it’s commonly known, is one of the most deadly and hard-to-kill superbugs. Tru-D SmartUVC uses chemical-free, environmentally-friendly UVC energy to kill C. diff and other deadly pathogens. UVC light has been proven to reduce the spread of C. diff in hospitals and health care

Read More
Posted 05.24.17
  • Share

Disinfection, Tru-D News, Tru-D Technology, Uncategorized

New eBook on UV Disinfection Available from Modern Healthcare

Enhanced disinfection strategies have become a focal point in health care as recent studies have shown that manual cleaning is not enough to stop the spread of pathogens in hospital settings. Not only do hospital-acquired infections affect the lives of hundreds of thousands of patients each year, but they also

Read More
Posted 05.19.17
  • Share

Industry News, Press, Studies, Tru-D News, Tru-D Technology, Uncategorized, Videos

UNC-TV Releases New Video Featuring Tru-D and the BETR-D Study

The University of North Carolina’s “UNC-TV” has released a new video on the Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study, the first and only randomized clinical trial on UV disinfection. The study proved that Tru-D could cut transmission of four major superbugs by a cumulative 30% among patients who entered the

Read More
Posted 05.18.17
  • Share

Tru-D News, Tru-D Technology, Uncategorized

UV Disinfection: Cost Savings to Hospitals

The direct medical cost of hospital-acquired infections (HAIs) to health care facilities exceeds $30 billion annually, and each HAI case can cost a hospital more than $15,000. As the penalties for HAIs increase and more superbugs are discovered each year, it’s critical for hospitals to reduce the risk of acquisition of

Read More
Posted 05.17.17
  • Share

Hospital News, Industry News, Press, Tru-D News, Tru-D Technology, Uncategorized

Tru-D Featured in Outpatient Surgery Magazine

Two of our hospital partners, St. Charles- Bend and Mission Hospital, were recently featured in an article in Outpatient Surgery Magazine.  In January, St. Charles-Bend brought in Tru-D for a 45-day trial. Satisfied with the results of reducing hospital-acquired infections (HAIs) without impeding room turnovers, the hospital now intends to

Read More
Posted 05.16.17
  • Share

Never miss the latest in UV news.
Subscribe to UVC360 today.

Sign Up »